Juliana Wilson
Medical · la Palma, CANPI 1851587919
Payments from drug & device makers
Across 69 payments — averaging $31.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$374
- AstraZeneca$324
- Novo Nordisk$299
- Amgen$296
- Johnson & Johnson$145
- Regeneron Healthcare Solutions, Inc.$139
- plus $570 from 14 others
What the payments were for
- Food & beverage$2,146100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 22 | $374 |
| AstraZeneca | 6 | $324 |
| Novo Nordisk | 7 | $299 |
| Amgen | 6 | $296 |
| Johnson & Johnson | 1 | $145 |
| Regeneron Healthcare Solutions, Inc. | 2 | $139 |
| AbbVie | 7 | $115 |
| Dexcom, Inc. | 1 | $101 |
| GSK | 4 | $75 |
| Bayer | 2 | $57 |
| Merck | 2 | $37 |
| Abiomed | 1 | $28 |
| Phathom Pharmaceuticals, Inc. | 1 | $26 |
| Exeltis, USA Inc. | 1 | $24 |
| Pfizer | 1 | $21 |
| Abbott | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Cranial Technologies, Inc | 1 | $16 |
| Sanofi | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Repatha$225
- XARELTO$145
- FARXIGA$125
- Wegovy$122
- BREZTRI$121
- RYBELSUS$120
- DUPIXENT$115
- DEXCOM G7 GSS (161)$101
- DEXCOM STELO GLUCOSE BIOSENSOR$101
How this compares
$2,146 in reported general payments places this provider in the 75th percentile of 2,087 medical providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine | 19 | $1,434 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 24 | $729 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 30 | $656 |
| Rosuvastatin Calcium | 12 | $359 |
| Metformin Hcl ErMetformin Hcl | 22 | $358 |
| Gabapentin | 15 | $346 |
| Atorvastatin Calcium | 45 | $239 |
| Levothyroxine Sodium | 27 | $237 |
| Metformin Hcl | 14 | $237 |
| Pioglitazone Hcl | 11 | $178 |
| Ibuprofen | 19 | $164 |
| Lisinopril | 25 | $136 |
| Amlodipine Besylate | 27 | $135 |
| Losartan Potassium | 12 | $132 |
| Omeprazole | 25 | $117 |
Paid to pharmacies, not to this prescriber.
Other medical in la Palma
- Nicola LowreyOrange$655K
- Justin LoveLoma Linda$553K
- David DoriguzziLancaster$514K
- Alison GracomIrvine$467K
- Jeffrey BonnaudLos Angeles$314K
- Ana TorresLaguna Beach$229K
- Heather ParlettRedlands$168K
- Deirdre MoxleyFullerton$149K
- Tri leGardena$127K
- Linda RankLadera Ranch$105K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.